Live News Categoriesequity

RCC (RCC) News

Follow RCC (RCC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol RCC Asset equity Sector Markets 90 days 1 Last 25.01 Updated Jul 20, 2026, 01:09 PM UTC Open live news feed Open RCC chart & news

L TRVI View GSK's decision to halt camlipixant in RCC as a positive for TRVI, ending the P2X3 class and leaving Haduvio the leading differenti TRVI View GSK's decision to halt camlipixant in RCC as a positive for TRVI, ending the P2X3 class and leaving Haduvio the leading differentiated candidate; Briley reiterate Buy and raise PT to $31 from $21 @ Briley EQUITY | Jul 20, 2026, 01:09 PM UTC